ストックスクリーナーアプリを入手
2.43
6.58%
0.15
プレマーケット:
2.49
0.06
+2.47%
Century Therapeutics Inc (IPSC) 最新ニュース
IPSC Financials: Income Statement, Balance Sheet & Cash Flow | Century Therapeutics, Inc. - Stock Titan
Should I buy Century Therapeutics Inc stock nowJuly 2025 Final Week & Weekly Watchlist for Consistent Profits - baoquankhu1.vn
Century Therapeutics, Inc. (NASDAQ:IPSC) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Century Therapeutics, Inc. (NASDAQ:IPSC) Short Interest Up 39.8% in February - MarketBeat
IPSC SEC FilingsCentury Therapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Aug Closing: How does Century Therapeutics Inc perform in inflationary periodsDollar Strength & Entry Point Confirmation Signals - baoquankhu1.vn
Century Therapeutics Inc expected to post a loss of 28 cents a shareEarnings Preview - TradingView
Century Therapeutics (NASDAQ:IPSC) Coverage Initiated by Analysts at TD Cowen - Defense World
Analysts Offer Insights on Healthcare Companies: Jazz Pharmaceuticals (JAZZ) and Century Therapeutics (IPSC) - The Globe and Mail
Movement Recap: Is Century Therapeutics Inc forming a bullish divergenceQuarterly Portfolio Report & Free Fast Gain Swing Trade Alerts - baoquankhu1.vn
Century Therapeutics to Participate in Upcoming Investor Conferences in March - Investing News Network
Century Therapeutics (NASDAQ:IPSC) Now Covered by Analysts at TD Cowen - MarketBeat
Stem cell therapy biotech Century Therapeutics heads to March investor events - Stock Titan
TD Cowen Initiates Century Therapeutics at Buy - marketscreener.com
TD Cowen initiates Century Therapeutics stock rating at Buy - Investing.com Australia
Financial Review: Century Therapeutics (NASDAQ:IPSC) and Hikma Pharmaceuticals (OTCMKTS:HKMPF) - Defense World
IPSCCentury Therapeutics, Inc. Latest Stock News & Market Updates - Stock Titan
What are the future prospects of Century Therapeutics Inc.2025 Support & Resistance & Fast Entry High Yield Stock Tips - mfd.ru
Point72 discloses 6.8% Century Therapeutics (IPSC) stake in 13G/A - Stock Titan
IPSC-derived NK Cells Clinical Trial Pipeline Gains Momentum: 12+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - GlobeNewswire Inc.
Is Century Therapeutics Inc. stock a dividend growth opportunityJuly 2025 Big Picture & Short-Term High Return Strategies - mfd.ru
Day Trade: Will Century Therapeutics Inc benefit from seasonality2025 Volume Leaders & High Accuracy Investment Signals - baoquankhu1.vn
Is Century Therapeutics Inc. forming a bullish divergence2025 Performance Recap & Low Volatility Stock Suggestions - mfd.ru
Clear Street reiterates Buy rating on Century Therapeutics stock at $6.60 - Investing.com Canada
Will Century Therapeutics Inc. stock benefit from automationGDP Growth & AI Enhanced Trade Execution Alerts - mfd.ru
Short Interest in Century Therapeutics, Inc. (NASDAQ:IPSC) Expands By 320.2% - MarketBeat
Bull Run: Will Century Therapeutics Inc stock go up in YEARShort Setup & Target Return Focused Stock Picks - baoquankhu1.vn
Is Century Therapeutics Inc. stock attractive for ETFs2025 Support & Resistance & Community Verified Trade Signals - mfd.ru
Century Therapeutics: A Very Promising Contender In The Type I Diabetes Mellitus Functional Cure Race - Seeking Alpha
Century Therapeutics, Inc. (NASDAQ:IPSC) Receives $3.80 Average PT from Brokerages - Defense World
Century Therapeutics, Inc. (NASDAQ:IPSC) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Century Therapeutics (IPSC) Price Target Increased by 10.75% to 4.20 - Nasdaq
Valuation Update: Is Oramed Pharmaceuticals Inc stock overvalued or fairly pricedMarket Growth Review & Real-Time Volume Analysis Alerts - baoquankhu1.vn
Chart Watch: Is Century Therapeutics Inc stock undervalued right nowSell Signal & Technical Confirmation Alerts - baoquankhu1.vn
Century Therapeutics (NASDAQ:IPSC) Lowered to "Sell" Rating by Wall Street Zen - MarketBeat
Century Therapeutics (NASDAQ:IPSC) Lowered to “Sell” Rating by Wall Street Zen - Defense World
Piper Sandler Highlights Century Therapeutics (IPSC) Cash Runway Through 2029, Upcoming IND Submission - Finviz
Risk Analysis: Will Century Therapeutics Inc benefit from current market trendsDollar Strength & Smart Money Movement Tracker - baoquankhu1.vn
Piper Sandler highlights Century Therapeutics (IPSC) cash runway through 2029, upcoming IND submission - MSN
7 Best Fast Growing Penny Stocks to Buy According to Analysts - Insider Monkey
Short Interest in Century Therapeutics, Inc. (NASDAQ:IPSC) Grows By 148.0% - MarketBeat
Why retail investors favor Century Therapeutics Inc. stockWeekly Trading Summary & High Accuracy Swing Entry Alerts - mfd.ru
Volume Report: Whats the RSI of Century Therapeutics Inc stock2025 Buyback Activity & Risk Managed Trade Strategies - baoquankhu1.vn
Are Biotech And Pharma Stocks Poised To Keep Climbing After Hitting 52-Week Highs? - Longbridge
Century Therapeutics (IPSC) upgraded to strong buy: Here's what you should know - MSN
Century Therapeutics (NASDAQ:IPSC) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Century Therapeutics Regains Nasdaq Compliance, Halts Reverse Split - TipRanks
How sensitive is Century Therapeutics Inc to inflationQuarterly Portfolio Summary & Safe Entry Momentum Stock Tips - baoquankhu1.vn
Century Therapeutics (IPSC) Upgraded to Strong Buy: Here's What You Should Know - Yahoo Finance
Deep Track Capital, LP's Strategic Acquisition of Century Therap - GuruFocus
Century Therapeutics stock price target raised to $4 from $2 at Piper Sandler - Investing.com India
Will Century Therapeutics Inc. stock deliver long term returnsTrend Reversal & Reliable Price Action Trade Plans - bollywoodhelpline.com
Big Money Moves: Will Century Therapeutics Inc benefit from seasonalityJuly 2025 Trends & Weekly Breakout Watchlists - baoquankhu1.vn
Short Interest in Century Therapeutics, Inc. (NASDAQ:IPSC) Rises By 32.1% - MarketBeat
Short Squeeze: Whats the RSI of Century Therapeutics Inc stockVolume Spike & Real-Time Buy Signal Alerts - baoquankhu1.vn
Brokerages Set Century Therapeutics, Inc. (NASDAQ:IPSC) PT at $3.40 - Defense World
Century Therapeutics, Inc Updates on Pipeline and Clinical Progress - TradingView — Track All Markets
Century Therapeutics, Inc. (NASDAQ:IPSC) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
0.11%
6.00%
大文字化:
|
ボリューム (24 時間):